Pyxis Oncology, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
PFIZER INC | 02/14/2025 | 7.03 M | $10.97 M | 100.00% | 11.58% |
LAURION CAPITAL MANAGEMENT LP | 02/14/2025 | 3.63 M | $5.66 M | 0.00% | 5.97% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 3.34 M | $5.22 M | 12.82% | 5.51% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 2.98 M | $4.65 M | 56.32% | 4.91% |
VANGUARD GROUP INC | 02/11/2025 | 2.44 M | $3.81 M | 0.34% | 4.02% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.08 M | $1.69 M | -0.21% | 1.78% |
PALO ALTO INVESTORS LP | 02/14/2025 | 1.04 M | $1.62 M | 510.25% | 1.71% |
ABRDN PLC | 01/24/2025 | 913,045 | $1.42 M | 0.00% | 1.50% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 832,200 | $1.30 M | 3,396.64% | 1.37% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 613,253 | $956,675 | -35.95% | 1.01% |
UBS GROUP AG | 02/14/2025 | 446,699 | $696,851 | 1,489.56% | 0.74% |
683 CAPITAL MANAGEMENT, LLC | 02/14/2025 | 415,000 | $647,400 | 0.08% | 0.68% |
HHLR ADVISORS, LTD. | 02/14/2025 | 382,606 | $596,865 | 0.00% | 0.63% |
RIDGEBACK CAPITAL INVESTMENTS L.P. | 02/14/2025 | 359,231 | $560,400 | 100.00% | 0.59% |
DECHENG CAPITAL LLC | 02/14/2025 | 326,810 | $509,824 | 0.00% | 0.54% |
AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 299,937 | $467,902 | 88.12% | 0.49% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 293,354 | $457,632 | 82.96% | 0.48% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 272,769 | $425,520 | 0.00% | 0.45% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 269,995 | $421,192 | 1.77% | 0.44% |
PERCEPTIVE ADVISORS LLC | 02/14/2025 | 188,462 | $294,001 | -62.93% | 0.31% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 184,702 | $288,135 | 32.75% | 0.30% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 181,042 | $282,426 | -36.17% | 0.30% |
MARSHALL WACE, LLP | 02/13/2025 | 157,953 | $246,407 | 35.75% | 0.26% |
UBS OCONNOR LLC | 02/14/2025 | 146,400 | $228,384 | 100.00% | 0.24% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 129,761 | $202,427 | 0.00% | 0.21% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 127,304 | $198,594 | -14.57% | 0.21% |
ARISTIDES CAPITAL LLC | 02/13/2025 | 124,000 | $193,440 | 100.00% | 0.20% |
SCHULHOFF & CO INC | 02/05/2025 | 122,000 | $190,320 | 0.00% | 0.20% |
MAIA WEALTH LLC | 02/05/2025 | 118,900 | $951 | 100.00% | 0.20% |
NEWEDGE WEALTH, LLC | 02/05/2025 | 116,009 | $180,974 | 0.00% | 0.19% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 111,051 | $173,239 | 35.52% | 0.18% |
PIER 88 INVESTMENT PARTNERS LLC | 02/12/2025 | 98,590 | $153,800 | -18.93% | 0.16% |
STATE OF WISCONSIN INVESTMENT BOARD | 02/14/2025 | 85,600 | $133,536 | 100.00% | 0.14% |
FMR LLC | 02/13/2025 | 84,888 | $132,425 | 2,037.16% | 0.14% |
LMR PARTNERS LLP | 02/14/2025 | 77,300 | $120,588 | -3.38% | 0.13% |
BARCLAYS PLC | 02/13/2025 | 77,013 | $121,000 | 20.17% | 0.13% |
YU FAN | 02/14/2025 | 69,303 | $108,113 | 0.00% | 0.11% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 67,975 | $106,041 | -20.79% | 0.11% |
RHUMBLINE ADVISERS | 01/30/2025 | 67,851 | $105,842 | 5.31% | 0.11% |
JANE STREET GROUP, LLC | 02/14/2025 | 67,686 | $105,590 | 36.58% | 0.11% |
CABLE CAR CAPITAL LLC | 02/14/2025 | 61,606 | $96,105 | 0.00% | 0.10% |
SEI INVESTMENTS CO | 02/11/2025 | 61,140 | $95,378 | 100.00% | 0.10% |
AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 50,080 | $78,125 | 100.00% | 0.08% |
UNIVERSITY OF CHICAGO | 02/05/2025 | 48,731 | $76,020 | 0.00% | 0.08% |
CITIGROUP INC | 02/12/2025 | 42,088 | $65,657 | 18.31% | 0.07% |
DEUTSCHE BANK AG\ | 02/14/2025 | 30,300 | $47,268 | -87.29% | 0.05% |
GRAHAM CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 30,287 | $47,248 | 100.00% | 0.05% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 28,949 | $45,161 | 19.50% | 0.05% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 28,011 | $43,697 | 4.54% | 0.05% |
ROYAL BANK OF CANADA | 02/14/2025 | 27,653 | $44,000 | -21.72% | 0.05% |
Pyxis Oncology, Inc. institutional Ownership - FAQ's
During the previous two years, 113 institutional investors and hedge funds held shares of Pyxis Oncology, Inc.. The most heavily invested institutionals were:
PFIZER INC: 7.03 M
Laurion Capital Management LP: 3.63 M
BlackRock Funding, Inc. /DE: 3.34 M
MILLENNIUM MANAGEMENT LLC: 2.98 M
VANGUARD GROUP INC: 2.44 M
GEODE CAPITAL MANAGEMENT, LLC: 1.08 M
51.94% of Pyxis Oncology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 34.39 M shares in the last 24 months. This purchase volume represents approximately $60.52 M in transactions.